BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11394952)

  • 1. Reasons women do not attend screening for cervical cancer: a population-based study in Sweden.
    Eaker S; Adami HO; Sparén P
    Prev Med; 2001 Jun; 32(6):482-91. PubMed ID: 11394952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlates of intent to seek unnecessary pap tests among elderly women.
    Zhang Y; Borders TF; Rohrer JE
    Womens Health Issues; 2007; 17(6):351-9. PubMed ID: 17936642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician recommendation for papanicolaou testing among U.S. women, 2000.
    Coughlin SS; Breslau ES; Thompson T; Benard VB
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1143-8. PubMed ID: 15894664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for cervical cancer among female physicians and their relatives in Taiwan: a population-based comparative study.
    Chen LS; Huang N; Tsay JH; Wang PJ; Chou YJ; Chou P; Lee CH
    Prev Med; 2007 Jun; 44(6):531-5. PubMed ID: 17467786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pap smear screening among urban Southwestern American Indian women.
    Risendal B; DeZapien J; Fowler B; Papenfuss M; Giuliano A
    Prev Med; 1999 Dec; 29(6 Pt 1):510-8. PubMed ID: 10600432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social and cultural barriers to Papanicolaou test screening in an urban population.
    Behbakht K; Lynch A; Teal S; Degeest K; Massad S
    Obstet Gynecol; 2004 Dec; 104(6):1355-61. PubMed ID: 15572502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How do women who choose not to participate in population-based cervical cancer screening reason about their decision?
    Blomberg K; Ternestedt BM; Törnberg S; Tishelman C
    Psychooncology; 2008 Jun; 17(6):561-9. PubMed ID: 17886262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAPRELA (Cancer Prevention for Latinas): findings of a pilot study in Winston-Salem, Forsyth County.
    Koval AE; Riganti AA; Foley KL
    N C Med J; 2006; 67(1):9-15. PubMed ID: 16550986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing Taiwan's high incidence of cervical cancer: factors associated with the Nation's low compliance with Papanicolaou screening in Taiwan.
    Liao CC; Wang HY; Lin RS; Hsieh CY; Sung FC
    Public Health; 2006 Dec; 120(12):1170-6. PubMed ID: 17074376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
    Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
    J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer screening among women in metropolitan areas of the United States by individual-level and area-based measures of socioeconomic status, 2000 to 2002.
    Coughlin SS; King J; Richards TB; Ekwueme DU
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2154-9. PubMed ID: 17119040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonattendance in a cervical cancer screening program - what happens if women's requirements are met?
    Oscarsson MG; Wijma BE; Benzein EG
    Health Care Women Int; 2008 Feb; 29(2):183-97. PubMed ID: 18350423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of cervical cancer screening in The Netherlands is mainly influenced by women's beliefs about the screening and by the inviting organization.
    Tacken MA; Braspenning JC; Hermens RP; Spreeuwenberg PM; van den Hoogen HJ; de Bakker DH; Groenewegen PP; Grol RP
    Eur J Public Health; 2007 Apr; 17(2):178-85. PubMed ID: 16837520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
    Nygård M; Daltveit AK; Thoresen SO; Nygård JF
    BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is a history of trauma associated with a reduced likelihood of cervical cancer screening?
    Farley M; Golding JM; Minkoff JR
    J Fam Pract; 2002 Oct; 51(10):827-31. PubMed ID: 12401150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the stages of adoption of cervical cancer screening among Korean women.
    Kwak MS; Choi KS; Spring BJ; Park S; Park EC
    Prev Med; 2009 Aug; 49(1):48-53. PubMed ID: 19465046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hispanic acculturation and utilization of cervical cancer screening in the US.
    Shah M; Zhu K; Wu H; Potter J
    Prev Med; 2006 Feb; 42(2):146-9. PubMed ID: 16297444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast and cervical carcinoma screening practices among women in rural and nonrural areas of the United States, 1998-1999.
    Coughlin SS; Thompson TD; Hall HI; Logan P; Uhler RJ
    Cancer; 2002 Jun; 94(11):2801-12. PubMed ID: 12115366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.